Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)

By Kay-Tee Khaw, Nick Wareham, Robert N. Luben, S. Bingham, S. Oakes, A. Welch, N. Day. British medical journal, 2001

1,105 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/6847728a8f138175d16544b432ae1095e1a5fb25

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. P. Zimmet
2. J. Shaw
3. Simin Liu
4. David W. Dunstan
5. V. Basevi
6. P. Cryer
7. Rury R. Holman
8. E. Ford

In Molecular Biology

1. Rury R. Holman
2. E. Ford
3. P. Zimmet

Citations in the corpus

• Hypoglycemia in diabetes. (2003, background): “This is supported by evidence of an increased risk of death from ischemic heart disease in people with glycated hemoglobin levels in the high normal range (7).”
• Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk (2004, background): “In a 3-year follow-up of men in a prospective study, we previously reported that hemoglobin A1c concentrations were related to cardiovascular disease and all-cause mortality (11).”
• High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. (2002, background): “Furthermore, recent data from the EPIC (European Prospective Investigation of Cancer and Nutrition)Norfolk prospective population study show that HbA1c concentration explains most of the excess mortality risk of diabetes, with an increase of one percentage point in HbA1c associated with a 28% increa”
• The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). (2001, background): “The importance of HbA "c as a continuous risk factor for CHD, in Type II diabetes, is underlined by the results of Table 4. A causal relationship between glycaemia, measured by HbA "c , and CHD has not been proved [16], but a predictive relationship has been established [18, 45 ].”
• Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. (2004, background): “Glycosylated hemoglobin level was predictive of CVD across the whole range of values in 1 cohort and had a higher predictive value for mortality than other CVD risk factors.(60) In this population, there was a suggestion, although not significant, that the glycosylated hemoglobin level is useful for”